Recent 8-K filings for IMUX

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 13, 2026 11:01 UTC earnings item 2.02item 9.01

  Immunic reports Q1 net loss $32.6M; cash $186.6M; Phase 3 MS data by end-2026

source · IMUX on sec.gov